Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Petros Pharmaceuticals to Participate in Two October 2022 Conferences

PTPI

NEW YORK, NY / ACCESSWIRE / October 21, 2022 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will participate in two October 2022 conferences.

LD Micro Main Event XV (Los Angeles, CA)
Presentation Date: Tuesday, October 25
Time: 4:30 pm PT (Track 4)

The conference is being held on October 25 - 27, 2022 at the Luxe Sunset Boulevard Hotel in Los Angeles. Register to watch the presentation here. Mr. Boctor will be available for one-on-one meetings throughout the conference.

23rd Annual Fall Scientific Meeting of SMSNA (Miami, FL)
Participation Dates: Thursday, October 27 - Sunday, October 30
Time: 9:00 am - 6:00 pm ET (Booth: 102)

The SMSNA is considered the premier society in North America dedicated to progress and education in sexual medicine. The conference is being held at the Loews Miami Beach Hotel. For more information visit: https://issmsmsna2022.org/

About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health, and substance use disorders.

# # #

CONTACT:
Jules Abraham
CORE IR
917-885-7378
pr@coreir.com

SOURCE: Petros Pharmaceuticals, Inc.



View source version on accesswire.com:
https://www.accesswire.com/721533/Petros-Pharmaceuticals-to-Participate-in-Two-October-2022-Conferences